Related references
Note: Only part of the references are listed.Concurrent activating KIT mutations in systemic mastocytosis
Terra Lasho et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value
A. Pardanani et al.
LEUKEMIA (2016)
Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation
Animesh Pardanani et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Myeloproliferative Neoplasms A Contemporary Review
Ayalew Tefferi et al.
JAMA ONCOLOGY (2015)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
A. Tefferi et al.
LEUKEMIA (2013)
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
Peter Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Hypereosinophilic Syndrome and Clonal Eosinophilia: Point-of-Care Diagnostic Algorithm and Treatment Update
Ayalew Tefferi et al.
MAYO CLINIC PROCEEDINGS (2010)
Share Paper
